BLGO OTC
BioLargo, Inc.
1W: -10.1%
1M: -14.9%
3M: -27.1%
YTD: -56.9%
1Y: -53.6%
3Y: -52.4%
5Y: -55.1%
$0.08
+0.00 (+3.03%)
Weekly Expected Move ±8.3%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$8M
-56.3% ▼
5Y CAGR: +26.1%
Gross Profit
$3M
-56.6% ▼
5Y CAGR: +22.6%
Operating Income
-$15M
-242.7% ▼
Net Income
-$12M
-390.4% ▼
EPS (Diluted)
$-0.04
-374.1% ▼
EBITDA
-$15M
-258.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3M | $6M | $12M | $18M | $8M |
| YoY Growth | +4.1% | +132.5% | +107.9% | +45.4% | -56.3% |
| Cost of Revenue | $1M | $3M | $6M | $10M | $4M |
| Gross Profit | $1M | $3M | $6M | $8M | $3M |
| Gross Margin | 43.6% | 48.6% | 50.3% | 44.2% | 43.9% |
| R&D Expenses | $1M | $1M | $2M | $3M | $3M |
| SG&A Expenses | $6M | $7M | $8M | $9M | $12M |
| Operating Expenses | $7M | $8M | $10M | $12M | $18M |
| Operating Income | -$6M | -$5M | -$4M | -$4M | -$15M |
| Operating Margin | -252.1% | -87.0% | -34.2% | -24.4% | -191.1% |
| Interest Expense | $234K | $53K | $91K | $139K | $540K |
| Income Before Tax | -$7M | -$5M | -$5M | -$2M | -$15M |
| Tax Expense | $0 | $0 | $13K | $2M | $0 |
| Net Income | -$7M | -$4M | -$4M | -$2M | -$12M |
| Net Margin | -291.5% | -76.4% | -28.7% | -13.5% | -151.7% |
| EPS (Diluted) | $-0.03 | $-0.02 | $-0.01 | $-0.01 | $-0.04 |
| EBITDA | -$7M | -$5M | -$4M | -$4M | -$15M |
| Shares Outstanding | 247M | 268M | 286M | 298M | 307M |